Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.39 - $2.02 $83,400 - $121,200
-60,000 Reduced 98.36%
1,000 $1,000
Q1 2023

May 12, 2023

BUY
$1.54 - $2.68 $81,721 - $142,216
53,066 Added 668.84%
61,000 $116,000
Q4 2022

Feb 10, 2023

SELL
$1.63 - $2.6 $518 - $826
-318 Reduced 3.85%
7,934 $19,000
Q3 2022

Nov 14, 2022

BUY
$1.57 - $2.38 $927 - $1,406
591 Added 7.71%
8,252 $11,000
Q2 2022

Aug 12, 2022

BUY
$1.96 - $3.05 $7,042 - $10,958
3,593 Added 88.32%
7,661 $15,000
Q1 2022

May 16, 2022

BUY
$2.41 - $3.24 $6,082 - $8,177
2,524 Added 163.47%
4,068 $12,000
Q4 2021

Feb 08, 2022

SELL
$3.02 - $4.13 $3,183 - $4,353
-1,054 Reduced 40.57%
1,544 $5,000
Q3 2021

Nov 15, 2021

SELL
$2.98 - $3.48 $38,322 - $44,752
-12,860 Reduced 83.19%
2,598 $8,000
Q2 2021

Sep 13, 2021

BUY
$3.01 - $3.78 $46,528 - $58,431
15,458 New
15,458 $51,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $35M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.